Literature DB >> 15277239

Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli.

Yong Zhou1, James S Hagood, Joanne E Murphy-Ullrich.   

Abstract

Distinct subpopulations of fibroblasts contribute to lung fibrosis, although the mechanisms underlying fibrogenesis in these subpopulations are not clear. Differential expression of the glycophosphatidylinositol-linked protein Thy-1 affects proliferation and myofibroblast differentiation. Lung fibroblast populations selected on the basis of Thy-1 expression by cell sorting were examined for responses to fibrogenic stimuli. Thy-1 (-) and Thy-1 (+) fibroblast populations were treated with platelet-derived growth factor-BB, interleukin-1beta, interleukin-4, or bleomycin and assessed for activation of transforming growth factor (TGF)-beta, Smad3 phosphorylation, and alpha-smooth muscle actin and fibronectin expression. Thy-1 (-) fibroblasts responded to these stimuli with increased TGF-beta activity, Smad3 phosphorylation, and expression of alpha-smooth muscle actin and fibronectin, whereas Thy-1 (+) fibroblasts resisted stimulation. The unresponsiveness of Thy-1 (+) cells is not because of defective TGF-beta signaling because both subsets respond to exogenous active TGF-beta. Rather, Thy-1 (-) fibroblasts activate latent TGF-beta in response to fibrogenic stimuli, whereas Thy-1 (+) cells fail to do so. Defective activation is common to multiple mechanisms of TGF-beta activation, including thrombospondin 1, matrix metalloproteinase, or plasmin. Thy-1 (-) lung fibroblasts transfected with Thy-1 also become resistant to fibrogenic stimulation, indicating that Thy-1 is a critical biological response modifier that protects against fibrotic progression by controlling TGF-beta activation. These studies provide a molecular basis for understanding the differential roles of fibroblast subpopulations in fibrotic lung disease through control of latent TGF-beta activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277239      PMCID: PMC1618578          DOI: 10.1016/s0002-9440(10)63330-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  57 in total

Review 1.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Differential expression, surface binding, and response to connective tissue growth factor in lung fibroblast subpopulations.

Authors:  J S Hagood; J A Lasky; J E Nesbitt; P Segarini
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

Review 3.  The myofibroblast in pulmonary fibrosis.

Authors:  Sem H Phan
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

4.  Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression.

Authors:  C Ramos; M Montaño; J García-Alvarez; V Ruiz; B D Uhal; M Selman; A Pardo
Journal:  Am J Respir Cell Mol Biol       Date:  2001-05       Impact factor: 6.914

5.  Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding.

Authors:  Y Morishima; A Nomura; Y Uchida; Y Noguchi; T Sakamoto; Y Ishii; Y Goto; K Masuyama; M J Zhang; K Hirano; M Mochizuki; M Ohtsuka; K Sekizawa
Journal:  Am J Respir Cell Mol Biol       Date:  2001-01       Impact factor: 6.914

6.  Tamoxifen and estrogen effects on TGF-beta formation: role of thrombospondin-1, alphavbeta3, and integrin-associated protein.

Authors:  J G Harpel; S Schultz-Cherry; J E Murphy-Ullrich; D B Rifkin
Journal:  Biochem Biophys Res Commun       Date:  2001-06-01       Impact factor: 3.575

7.  A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat.

Authors:  T Yehualaeshet; R O'Connor; A Begleiter; J E Murphy-Ullrich; R Silverstein; N Khalil
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

8.  Induction of telomerase activity in fibroblasts from bleomycin-injured lungs.

Authors:  Y Nozaki; T Liu; K Hatano; M Gharaee-Kermani; S H Phan
Journal:  Am J Respir Cell Mol Biol       Date:  2000-10       Impact factor: 6.914

9.  Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.

Authors:  T Yehualaeshet; R O'Connor; J Green-Johnson; S Mai; R Silverstein; J E Murphy-Ullrich; N Khalil
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 10.  Interstitial fibrosis and growth factors.

Authors:  J A Lasky; A R Brody
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

View more
  54 in total

1.  The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Authors:  Mariya T Sweetwyne; Manuel A Pallero; Ailing Lu; Lauren Van Duyn Graham; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts.

Authors:  Yan Y Sanders; Pallavi Kumbla; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-07       Impact factor: 6.914

3.  Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.

Authors:  Yan Y Sanders; Annie Pardo; Moisés Selman; Gerard J Nuovo; Trygve O Tollefsbol; Gene P Siegal; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-12       Impact factor: 6.914

4.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

5.  Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.

Authors:  Hongmei Gu; Amanda J Fisher; Elizabeth A Mickler; Frank Duerson; Oscar W Cummings; Marc Peters-Golden; Homer L Twigg; Trent M Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

Review 6.  Epigenetic contributions to the developmental origins of adult lung disease.

Authors:  Lisa A Joss-Moore; Robert H Lane; Kurt H Albertine
Journal:  Biochem Cell Biol       Date:  2014-10-13       Impact factor: 3.626

Review 7.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

8.  miR-145 regulates myofibroblast differentiation and lung fibrosis.

Authors:  Shanzhong Yang; Huachun Cui; Na Xie; Mert Icyuz; Sami Banerjee; Veena B Antony; Edward Abraham; Victor J Thannickal; Gang Liu
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

9.  Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.

Authors:  Yong Zhou; Katri Koli; James S Hagood; Mi Miao; Mahendra Mavalli; Daniel B Rifkin; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

10.  Thy-1 attenuates TNF-alpha-activated gene expression in mouse embryonic fibroblasts via Src family kinase.

Authors:  Bin Shan; James S Hagood; Ying Zhuo; Hong T Nguyen; Mark MacEwen; Gilbert F Morris; Joseph A Lasky
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.